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Systemic lupus erythematosus (SLE) is an 
autoimmune disease which predominantly affects 
women of childbearing age. Likewise, patients 
suffering from SLE are at a higher risk of 
developing other autoimmune diseases. 
Neuromyelitis optica (NMO), is a rare 
inflammatory demyelinating affliction of the 
central nervous system (CNS) principally 
characterized by recurrent optic neuritis (ON) and 
longitudinal extensive transverse myelitis 
(LETM).1 
We report a case of a 30-year-old woman at  
6 weeks of her second pregnancy with a  
three-year history of controlled SLE that was 
subsequently identified to have a NMO. 
She had been presenting a dexter paraplegia 
from inception of pregnancy. Her unexpected 
numbness primarily had started in both lower 
extremities (especially right leg) and then, 
increasingly had progressed to the waist with 
arthralgia for 5 months. Visual evoked potential 
(VEP) was performed, by virtue of her complaints 
of blurred vision and abnormal VEP in both eyes. 
She had denied headache, dizziness, diplopia, 
fever and no history of respiratory, urinary and 
gastrointestinal problems. Moreover, she had a 
discoid rash on her right cheek.  
On physical examination, she was oriented, 
well-nourished and her cranial nerves were intact. 
Besides, on musculoskeletal assessment, arthritis 
symptoms were not recognized though she was 
slow to perform tasks. She had a revealing 
enervation in all extremities and her motor 
strength was at a rate of 2/5. Upper motor neuron 
dysfunction was suggested according to positive 
Babinski sign and superficial abdominal 
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hyporeflexia.  
Routine blood tests and chemistry analysis 
including complete blood count (CBC), thyroid 
stimulating hormone and coagulation tests were 
unremarkable. Autoimmune markers such as 
rheumatoid factor, lupus anti-coagulant and anti-
phospholipid antibodies including anti-
cardiolipin and anti-2-glycoprotein were negative 
but her anti-Sjögren's-syndrome-related antigen-
A (anti-SS-A) test, anti-nuclear antibody (ANA) and 
NMO-IgG test were positive. She had decreased 
level of serum complement factor; C3 and T4 levels 
were raised in assessment of thyroid function.  
Normal magnetic resonance imaging (MRI) of 
the brain was seen without plaques. Thoracic cord 
MRI revealed hyperintense signal lesions from 
cervical segment 5 to thoracic segment 4  
(7 hyperintense demyelinated segments). In 
addition, hyperintense signal at the thoracic spine 
level with holocord involvement was seen. 
According to patient’s history (discoid rash), 
physical examination results (paraplegia), 
autoimmune tests (positive NMO-IgG) and 
imaging findings (LETM), a diagnosis of NMO 
secondary to an acute SLE flair was formed. 
The patient was treated with 400 mg of oral 
hydroxychloroquine once a day for 3 months, and 
she had no further cutaneous or articular 
symptoms. At the 8th week of gestation, she had 
abortion and three pulses of intravenous  
methyl-prednisolone and daily pulse of 
cyclophosphamide were administered. Since her 
condition had not improved after receiving 
therapy, four sessions of plasmapheresis with  
3 liters volume and fresh frozen plasma (FFP) 
replacement was done. Significant improvement 
was observed after plasmapheresis, and the 
patient limb’s motility recurred.  
SLE is a multisystem autoimmune disease, 
which its pathophysiology may have 
consequences on all components of the CNS. The 
CNS and peripheral nervous systems (PNS) may 
be involved in SLE. It is well known that NMO is 
closely linked with other autoimmune diseases; 
however it has been barely reported in patients 
with SLE. Our case has an extensive role in 
justifying the fact that the contact between SLE 
and NMO can happen during the life span. Mula 
et al. have hypothesized that early treatment, by 
combination of plasmapheresis and 
immunosuppressive agents, may be related to 
more beneficial conclusion in patients with SLE 
and longitudinal myelitis (LM).2 In a similar case 
report study, a patient with 19 myelitis attacks 
was reported during rituximab therapy.3 However, 
our case experienced one myelitis attack from her 
NMO onset that substantially improved after 
plasmapheresis with 6 months follow-up.  
From the immunological perspective, cell-
mediated immunity converts to increased 
humoral immunity in normal pregnancy. 
Pregnancy tends to aggravate NMO and SLE 
which are B-cell-mediated autoimmune diseases. 
On the other hand, previous studies declare that 
NMO-IgG can damage placenta and cause fetal 
death in mice.4  
A study reported a case of SLE in 28-year-old 
women, who diagnosed NMO in the fourth 
month of her pregnancy. In that case, the patient 
did not have such a favorable consequence.5 
Therefore, since SLE-associated NMO generally 
has a poor prognosis and possibly prompting 
disability and may be the cause to abortion, early 
diagnosis seems essential.  
In conclusion, considering the fact that the 
incidence of NMO in an underlying autoimmune 
connective tissue disease represents a  
co-occurrence of two autoimmune disorders, 
pregnancy could be suggested as a trigger for this 
concurrency. Eventually as occurrence of NMO in 
patients with SLE, especially in pregnancy, is 
extraordinary, specific researches with 
collaboration from several groups would be 
invaluable in order to overcome the limitation of 
papers such as this one. 
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